Axogen Net Worth
Axogen Net Worth Breakdown | AXGN |
Axogen Net Worth Analysis
Axogen's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Axogen's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Axogen's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Axogen's net worth analysis. One common approach is to calculate Axogen's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Axogen's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Axogen's net worth. This approach calculates the present value of Axogen's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Axogen's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Axogen's net worth. This involves comparing Axogen's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Axogen's net worth relative to its peers.
Enterprise Value |
|
To determine if Axogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Axogen's net worth research are outlined below:
| Axogen Inc had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 141.98 M. | |
| Over 82.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Disposition of 4003 shares by Jens Kemp of Axogen at 18.36 subject to Rule 16b-3 |
Axogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Axogen Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Axogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Axogen Target Price Consensus
Axogen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Axogen's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Strong Buy |
Most Axogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Axogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Axogen Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAxogen Target Price Projection
Axogen's current and average target prices are 18.28 and 18.50, respectively. The current price of Axogen is the price at which Axogen Inc is currently trading. On the other hand, Axogen's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Axogen Target Price
Know Axogen's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Axogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Axogen Inc backward and forwards among themselves. Axogen's institutional investor refers to the entity that pools money to purchase Axogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-12-31 | 772.8 K | Armistice Capital, Llc | 2024-12-31 | 613 K | Deutsche Bank Ag | 2024-12-31 | 594.8 K | Tocqueville Asset Management L.p. | 2024-12-31 | 589.9 K | Silvercrest Asset Management Group Llc | 2024-12-31 | 583.6 K | D. E. Shaw & Co Lp | 2024-12-31 | 488.3 K | Prudential Financial Inc | 2024-12-31 | 418.3 K | Charles Schwab Investment Management Inc | 2024-12-31 | 416.6 K | Bank Of America Corp | 2024-12-31 | 402.5 K | First Light Asset Management, Llc | 2024-12-31 | 4.5 M | Blackrock Inc | 2024-12-31 | 3.4 M |
Follow Axogen's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 764.93 M.Market Cap |
|
Project Axogen's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.05) | (0.05) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.10) | (0.10) |
When accessing Axogen's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Axogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Axogen's profitability and make more informed investment decisions.
Evaluate Axogen's management efficiency
Axogen Inc has return on total asset (ROA) of (0.0103) % which means that it has lost $0.0103 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0999) %, meaning that it created substantial loss on money invested by shareholders. Axogen's management efficiency ratios could be used to measure how well Axogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 17th of March 2025, Return On Tangible Assets is likely to drop to -0.05. In addition to that, Return On Capital Employed is likely to grow to -0.02. At this time, Axogen's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.35 | 1.50 | |
| Tangible Book Value Per Share | 2.22 | 1.45 | |
| Enterprise Value Over EBITDA | 126.75 | 133.09 | |
| Price Book Value Ratio | 7.02 | 12.77 | |
| Enterprise Value Multiple | 126.75 | 133.09 | |
| Price Fair Value | 7.02 | 12.77 | |
| Enterprise Value | 770.5 M | 809 M |
At Axogen Inc, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 4.2758 | Revenue | Quarterly Revenue Growth 0.151 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Axogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Axogen Corporate Filings
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 4th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 26th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
| 3rd of February 2025 Other Reports | ViewVerify |
Axogen Earnings Estimation Breakdown
The calculation of Axogen's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Axogen is estimated to be 0.016 with the future projection ranging from a low of -0.05 to a high of 0.06. Please be aware that this consensus of annual earnings estimates for Axogen Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.05 Lowest | Expected EPS | 0.06 Highest |
Axogen Earnings Projection Consensus
Suppose the current estimates of Axogen's value are higher than the current market price of the Axogen stock. In this case, investors may conclude that Axogen is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Axogen's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 7 | 29.91% | 0.07 | 0.016 | -0.23 |
Axogen Earnings per Share Projection vs Actual
Actual Earning per Share of Axogen refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Axogen Inc predict the company's earnings will be in the future. The higher the earnings per share of Axogen, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Axogen Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Axogen, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Axogen should always be considered in relation to other companies to make a more educated investment decision.Axogen Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Axogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-12-31 | 2024-12-31 | 0.036 | 0.07 | 0.034 | 94 | ||
2024-11-07 | 2024-09-30 | 0.01 | 0.07 | 0.06 | 600 | ||
2024-08-08 | 2024-06-30 | -0.04 | 0.05 | 0.09 | 225 | ||
2024-05-02 | 2024-03-31 | -0.07 | -0.06 | 0.01 | 14 | ||
2024-03-05 | 2023-12-31 | -0.1 | -0.06 | 0.04 | 40 | ||
2023-11-07 | 2023-09-30 | -0.06 | 0.01 | 0.07 | 116 | ||
2023-08-07 | 2023-06-30 | -0.13 | -0.03 | 0.1 | 76 | ||
2023-05-09 | 2023-03-31 | -0.14 | -0.1 | 0.04 | 28 | ||
2023-03-14 | 2022-12-31 | -0.11 | -0.03 | 0.08 | 72 | ||
2022-11-08 | 2022-09-30 | -0.12 | -0.01 | 0.11 | 91 | ||
2022-08-03 | 2022-06-30 | -0.14 | -0.06 | 0.08 | 57 | ||
2022-05-04 | 2022-03-31 | -0.15 | -0.2 | -0.05 | 33 | ||
2022-02-22 | 2021-12-31 | -0.13 | -0.08 | 0.05 | 38 | ||
2021-11-03 | 2021-09-30 | -0.14 | -0.09 | 0.05 | 35 | ||
2021-08-04 | 2021-06-30 | -0.13 | -0.09 | 0.04 | 30 | ||
2021-05-05 | 2021-03-31 | -0.16 | -0.08 | 0.08 | 50 | ||
2021-02-22 | 2020-12-31 | -0.12 | -0.08 | 0.04 | 33 | ||
2020-10-29 | 2020-09-30 | -0.14 | 0.04 | 0.18 | 128 | ||
2020-08-05 | 2020-06-30 | -0.38 | -0.15 | 0.23 | 60 | ||
2020-05-06 | 2020-03-31 | -0.15 | -0.19 | -0.04 | 26 | ||
2020-02-24 | 2019-12-31 | -0.09 | -0.1 | -0.01 | 11 | ||
2019-11-06 | 2019-09-30 | -0.11 | -0.07 | 0.04 | 36 | ||
2019-08-06 | 2019-06-30 | -0.14 | -0.1 | 0.04 | 28 | ||
2019-05-08 | 2019-03-31 | -0.15 | -0.15 | 0.0 | 0 | ||
2019-02-26 | 2018-12-31 | -0.05 | -0.09 | -0.04 | 80 | ||
2018-10-29 | 2018-09-30 | -0.05 | -0.05 | 0.0 | 0 | ||
2018-08-01 | 2018-06-30 | -0.09 | -0.09 | 0.0 | 0 | ||
2018-04-30 | 2018-03-31 | -0.11 | -0.16 | -0.05 | 45 | ||
2018-02-28 | 2017-12-31 | -0.08 | -0.07 | 0.01 | 12 | ||
2017-11-01 | 2017-09-30 | -0.06 | -0.06 | 0.0 | 0 | ||
2017-08-02 | 2017-06-30 | -0.08 | -0.06 | 0.02 | 25 | ||
2017-05-04 | 2017-03-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2017-02-22 | 2016-12-31 | -0.08 | -0.1 | -0.02 | 25 | ||
2016-11-02 | 2016-09-30 | -0.08 | -0.08 | 0.0 | 0 | ||
2016-08-03 | 2016-06-30 | -0.12 | -0.09 | 0.03 | 25 | ||
2016-05-04 | 2016-03-31 | -0.12 | -0.12 | 0.0 | 0 | ||
2016-02-29 | 2015-12-31 | -0.12 | -0.12 | 0.0 | 0 | ||
2015-11-05 | 2015-09-30 | -0.13 | -0.11 | 0.02 | 15 | ||
2015-08-06 | 2015-06-30 | -0.14 | -0.13 | 0.01 | 7 | ||
2015-05-05 | 2015-03-31 | -0.15 | -0.16 | -0.01 | 6 | ||
2015-03-05 | 2014-12-31 | -0.15 | -0.21 | -0.06 | 40 | ||
2014-11-13 | 2014-09-30 | -0.2 | -0.19 | 0.01 | 5 | ||
2014-08-04 | 2014-06-30 | -0.22 | -0.21 | 0.01 | 4 | ||
2014-04-30 | 2014-03-31 | -0.23 | -0.24 | -0.01 | 4 | ||
2014-03-06 | 2013-12-31 | -0.22 | -0.24 | -0.02 | 9 | ||
2013-10-30 | 2013-09-30 | -0.21 | -0.25 | -0.04 | 19 | ||
2013-07-11 | 2013-06-30 | -0.28 | -0.31 | -0.03 | 10 | ||
2013-04-30 | 2013-03-31 | -0.28 | -0.31 | -0.03 | 10 | ||
2013-03-12 | 2012-12-31 | -0.21 | -0.36 | -0.15 | 71 | ||
2012-11-07 | 2012-09-30 | -0.18 | -0.2 | -0.02 | 11 | ||
2012-08-14 | 2012-06-30 | -0.18 | -0.16 | 0.02 | 11 | ||
2012-05-14 | 2012-03-31 | -0.19 | -0.19 | 0.0 | 0 | ||
2012-03-14 | 2011-12-31 | -0.22 | -0.58 | -0.36 | 163 | ||
1995-02-01 | 1994-12-31 | 0.09 | 0.01 | -0.08 | 88 | ||
1994-10-31 | 1994-09-30 | 0.1 | 0.02 | -0.08 | 80 | ||
1994-09-07 | 1994-06-30 | 0.05 | 0.03 | -0.02 | 40 | ||
1994-04-26 | 1994-03-31 | 0 | 0.01 | 0.01 | 0 | ||
1994-01-26 | 1993-12-31 | 0.09 | 0.07 | -0.02 | 22 |
Axogen Corporate Executives
Elected by the shareholders, the Axogen's board of directors comprises two types of representatives: Axogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axogen. The board's role is to monitor Axogen's management team and ensure that shareholders' interests are well served. Axogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Mariani | Ex CFO | Profile |
Already Invested in Axogen Inc?
The danger of trading Axogen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Axogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Axogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Axogen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share | Quarterly Revenue Growth 0.151 | Return On Assets | Return On Equity |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.